What began decades ago as the discovery of an antibody from mice that targets human cancer cells is now undergoing human trials in the US as the basis of a treatment for acute leukaemia.
The antibody targets a protein called EphA3, which is found in about half of all acute leukaemias as well as many other human cancers including a significant proportion of malignant melanomas, brain tumours and lung cancers. The antibody, called KB004, has been shown to kill certain types of cancerous tumours grown from human samples. Continue reading Life’s work closer to saving lives→
An Australian invention is making it cheaper, quicker and safer to manufacture the radioactive tracers used in latest medical imaging techniques to track down increasingly smaller clusters of cancer cells.
Like preparing a cake in a mixing bowl, the chemical reactions to make the tracers involve putting the ingredients together in the right proportions. The next generation of tracers can have a more complex recipe—and so can be more difficult to produce using just one ‘mixing bowl’ at a time. Continue reading Two steps forward for cancer detection→
There’s a new diagnostic tool being developed to target melanoma, the deadly form of skin cancer with which more than 10,000 Australians are diagnosed each year.
It’s a chemical compound designed to highlight small traces of these cancer cells in the body.
Melanoma occurs when the cells that make melanin, the dark pigment normally found in the skin, become cancerous. Melanoma cells often spread elsewhere in the body before the primary tumours are detected and removed surgically. Clusters of these melanoma cells can be hard to detect before they grow into tumours by which time they are often incurable. Continue reading Unmasking melanoma early→
Imagine printing your own room lighting, lasers, or solar cells from inks you buy at the local newsagent. Jacek Jasieniak and colleagues at CSIRO, the University of Melbourne and the University of Padua in Italy, have developed liquid inks based on quantum dots that can be used to print such devices and in the first demonstration of their technology have produced tiny lasers. Quantum dots are made of semiconductor material grown as nanometre-sized crystals, around a millionth of a millimetre in diameter. The laser colour they produce can be selectively tuned by varying their size.
High tech cling wraps that ‘sieve out’ carbon dioxide from waste gases can help save the world, says Melbourne University chemical engineer, Colin Scholes who developed the technology. The membranes can be fitted to existing chimneys where they capture CO2 for removal and storage. Not only are the new membranes efficient, they are also relatively cheap to produce. They are already being tested on brown coal power stations in Victoria’s La Trobe Valley, Colin says. “We are hoping these membranes will cut emissions from power stations by up to 90 per cent.”
Queensland researchers believe future cancer drugs could be grown in sunflowers and ultimately delivered as a seed ‘pill’.
They’re a long way from that outcome. But, as they reported to the XVIII International Botanical Congress in Melbourne earlier this year, they have already shown that sunflowers make a precursor to cancer drugs as part of their defence against insect attack.
Blood tests using nanoparticles carrying molecules which can detect breast cancer biomarkers could save millions of lives and open the way to mass screening for many cancers.
Prof. Matt Trau, of the Australian Institute for Bioengineering & Nanotechnology at the University of Queensland, and his team are using a combination of nanotechnology and molecular biology in the project, funded by a five-year $5 million grant from the National Breast Cancer Foundation.
Researchers in Melbourne will trial a new procedure to reconstruct breasts in patients following mastectomy. The procedure will use the women’s own stem cells instead of silicon.
Focusing on the treatment and recovery of women with breast cancer, the new technique known as Neopec involves the insertion of a customised biodegradable chamber which is contoured to match the woman’s natural breast shape. The chamber acts as a scaffold within which the woman’s own stem cells are used to grow permanent breast fat tissue.
Australia’s iconic kangaroo may hold the secret for the war on cancer. Assoc. Prof. Ming Wei from the Griffith Institute of Health and Medical Research is using commensal bacteria found in kangaroos to develop anti-cancer agents that are expected to be effective in combating solid tumours, which account for up to 90 per cent of cancers.